article Open Access
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
British Journal of Cancer · 2003 · Vol. 89(6) · pp. 1028–1030
L M Forrest✉(Glasgow Royal Infirmary)Donald C. McMillan(Glasgow Royal Infirmary)C S McArdle(Glasgow Royal Infirmary)Wilson J. Angerson(Glasgow Royal Infirmary)David J. Dunlop(Glasgow Royal Infirmary)
Abstract
A score based on the combination of the systemic inflammatory response and albumin hazards ratio (HR) 1.70, 95% CI 1.23 - 2.35, P=0.001) was comparable in prognostic value to that based on stage and performance status (HR 1.48, 95% CI 1.12 - 1.95, P=0.006) in patients with inoperable non-small-cell lung cancer. The former is simple to measure and well standardised.
Inflammatory Biomarkers in Disease PrognosisVenous Thromboembolism Diagnosis and ManagementCancer Immunotherapy and BiomarkersMedicineInternal medicineOncologyLung cancerProportional hazards modelStage (stratigraphy)CancerGastroenterology
MeSH terms
AdenocarcinomaAlbuminsC-Reactive ProteinCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellFemaleHumansInflammationLung NeoplasmsMaleMiddle AgedNeoplasm StagingPrognosisProspective StudiesRetrospective Studies
Citations
771
FWCI
2.39
field-weighted impact
References
16
Percentile
88%
vs. same field & year
Citations per year
Cited by
References
A New International Staging System for Lung Cancer
CHEST Journal · 1986 · 1,666 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
